THE EFFECTS OF STEROID WITHDRAWAL ON THE LIPOPROTEIN PROFILES OF CYCLOSPORINE-TREATED KIDNEY AND KIDNEY-PANCREAS TRANSPLANT RECIPIENTS

被引：92

作者：

HRICIK, DE

BARTUCCI, MR

MAYES, JT

SCHULAK, JA

机构：

[1] UNIV HOSP CLEVELAND,SERV TRANSPLANTAT,CLEVELAND,OH 44106

[2] CASE WESTERN RESERVE UNIV,SCH MED,DEPT MED,CLEVELAND,OH 44106

[3] CASE WESTERN RESERVE UNIV,SCH MED,DEPT SURG,CLEVELAND,OH 44106

来源：

TRANSPLANTATION | 1992年 / 54卷 / 05期

关键词：

D O I：

10.1097/00007890-199211000-00019

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Lipoprotein profiles were measured before and two months after complete withdrawal of prednisone in 34 kidney and 9 kidney-pancreas transplant recipients subsequently maintained on cyclosporine and azathioprine. Withdrawal of steroid therapy was accompanied by a 17% reduction in total serum cholesterol levels. However, there was a parallel reduction in all other measured lipoprotein concentrations, including an 18% reduction in high-density lipoprotein cholesterol levels. In diabetic recipients of a kidney or kidney-pancreas transplant, the ratio of total to high-density lipoprotein cholesterol was unchanged after steroid withdrawal. In nondiabetic kidney transplant recipients, this ratio actually increased significantly following withdrawal of prednisone. These observations suggest that it is premature to presume that withdrawal of steroid therapy will reduce the cardiovascular risk related to hyperlipidemia in cyclosporine-treated kidney or kidney-pancreas transplant recipients.

引用

页码：868 / 871

页数：4

共 16 条

[1] EFFECTS OF CYCLOSPORINE THERAPY ON PLASMA-LIPOPROTEIN LEVELS
BALLANTYNE, CM
PODET, EJ
PATSCH, WP
HARATI, Y
APPEL, V
GOTTO, AM
YOUNG, JB
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 262 (01): : 53 - 56
[2] BRY W, 1991, TRANSPLANT P, V23, P994
[3] LIPOPROTEINS, CARDIOVASCULAR-DISEASE, AND DEATH - THE FRAMINGHAM-STUDY
GORDON, T
KANNEL, WB
CASTELLI, WP
DAWBER, TR
[J]. ARCHIVES OF INTERNAL MEDICINE, 1981, 141 (09) : 1128 - 1131
[4] GULANIKAR AC, 1991, TRANSPLANT P, V23, P990
[5] VARIABLE EFFECTS OF STEROID WITHDRAWAL ON BLOOD-PRESSURE REDUCTION IN CYCLOSPORINE-TREATED RENAL-TRANSPLANT RECIPIENTS
HRICIK, DE
LAUTMAN, J
BARTUCCI, MR
MOIR, EJ
MAYES, JT
SCHULAK, JA
[J]. TRANSPLANTATION, 1992, 53 (06) : 1232 - 1235
[6] HRICIK DE, 1991, AM J KIDNEY DIS, V18, P353
[7] WITHDRAWAL OF STEROIDS AFTER RENAL-TRANSPLANTATION - CLINICAL PREDICTORS OF OUTCOME
HRICIK, DE
WHALEN, CC
LAUTMAN, J
BARTUCCI, MR
MOIR, EJ
MAYES, JT
SCHULAK, JA
[J]. TRANSPLANTATION, 1992, 53 (01) : 41 - 45
[8] EFFECTS OF STEROID WITHDRAWAL ON POSTTRANSPLANT DIABETES-MELLITUS IN CYCLOSPORINE-TREATED RENAL-TRANSPLANT RECIPIENTS
HRICIK, DE
BARTUCCI, MR
MOIR, EJ
MAYES, JT
SCHULAK, JA
[J]. TRANSPLANTATION, 1991, 51 (02) : 374 - 377
[9] THE ADVERSE IMPACT OF CYCLOSPORINE ON SERUM-LIPIDS IN RENAL-TRANSPLANT RECIPIENTS
KASISKE, BL
TORTORICE, KL
HEIMDUTHOY, KL
AWNI, WM
RAO, KV
[J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 17 (06) : 700 - 707
[10] PERSISTENT HYPERLIPIDEMIA IN RENAL-TRANSPLANT PATIENTS
KASISKE, BL
UMEN, AJ
[J]. MEDICINE, 1987, 66 (04) : 309 - 316

← 1 2 →